Deutsche Bank AG Has $1.38 Million Stock Holdings in Ingevity Co. (NYSE:NGVT)

Deutsche Bank AG raised its position in Ingevity Co. (NYSE:NGVT - Free Report) by 53.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 33,936 shares of the company's stock after acquiring an additional 11,801 shares during the period. Deutsche Bank AG owned approximately 0.09% of Ingevity worth $1,383,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. KBC Group NV grew its holdings in Ingevity by 27.5% in the fourth quarter. KBC Group NV now owns 2,007 shares of the company's stock valued at $82,000 after purchasing an additional 433 shares during the last quarter. Empowered Funds LLC acquired a new position in Ingevity during the fourth quarter worth about $187,000. O Shaughnessy Asset Management LLC acquired a new position in Ingevity during the fourth quarter worth about $214,000. Teacher Retirement System of Texas purchased a new stake in shares of Ingevity during the fourth quarter worth about $237,000. Finally, Balyasny Asset Management L.P. purchased a new stake in shares of Ingevity during the fourth quarter worth about $302,000. Institutional investors and hedge funds own 91.59% of the company's stock.

Ingevity Trading Down 2.4%

Shares of NGVT traded down $1.04 during midday trading on Wednesday, hitting $42.71. The stock had a trading volume of 176,716 shares, compared to its average volume of 279,964. Ingevity Co. has a fifty-two week low of $28.49 and a fifty-two week high of $51.67. The business has a 50-day simple moving average of $36.89 and a two-hundred day simple moving average of $42.06. The firm has a market cap of $1.56 billion, a P/E ratio of -3.61 and a beta of 1.31. The company has a current ratio of 1.87, a quick ratio of 1.04 and a debt-to-equity ratio of 6.86.

Ingevity (NYSE:NGVT - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.74 by $0.25. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. The firm had revenue of $284.00 million for the quarter, compared to analyst estimates of $299.13 million. During the same quarter last year, the firm earned $0.47 earnings per share. The company's revenue for the quarter was down 16.5% on a year-over-year basis. As a group, equities analysts forecast that Ingevity Co. will post 4.45 EPS for the current year.

Analyst Upgrades and Downgrades

NGVT has been the subject of a number of recent analyst reports. Wall Street Zen downgraded shares of Ingevity from a "buy" rating to a "hold" rating in a report on Saturday, April 12th. BMO Capital Markets upgraded shares of Ingevity from a "market perform" rating to an "outperform" rating and upped their target price for the company from $62.00 to $65.00 in a research note on Wednesday, February 26th. Finally, Wells Fargo & Company upped their target price on shares of Ingevity from $32.00 to $38.00 and gave the company an "equal weight" rating in a research note on Wednesday, May 7th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, Ingevity currently has an average rating of "Moderate Buy" and a consensus price target of $52.75.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.